國立高雄大學圖資館 |

Language: English

Back

Principles of cancer treatment and a...

Link, Wolfgang.

Principles of cancer treatment and anticancer drug development

Record Type:	Electronic resources : Monograph/item
Title/Author:	Principles of cancer treatment and anticancer drug developmentby Wolfgang Link.
Author:	Link, Wolfgang.
Published:	Cham :Springer International Publishing :2019.
Description:	xiv, 145 p. :ill. (some col.), digital ;24 cm.
Contained By:	Springer eBooks
Subject:	CancerChemotherapy.
Online resource:	https://doi.org/10.1007/978-3-030-18722-4
ISBN:	9783030187224$q(electronic bk.)

Principles of cancer treatment and anticancer drug development
Link, Wolfgang.

Principles of cancer treatment and anticancer drug development[electronic resource] /by Wolfgang Link. - Cham :Springer International Publishing :2019. - xiv, 145 p. :ill. (some col.), digital ;24 cm.

Preface -- Acknowledgements -- Contents -- Abbreviations -- Introduction -- Cancer Therapy -- Cancer drug resistance -- Drug Discovery and Development -- Economic and social implications of modern drug discovery. Index.

This book explains how current medicines against cancer work and how we find new ones. It provides an easy-to-understand overview of current options to treat patients with cancer, which includes Surgery, Radiation therapy, Chemotherapy, Targeted therapy and Immunotherapy. The efficiency of all these treatments is limited by the capacity of cancer cells to escape therapy. This book explains the mechanisms of anti-cancer drug resistance and strategies to overcome it. The discovery and development process of a new drug is detailed beginning with the identification and validation of a therapeutic target, the identification of an inhibitor of the target and its subsequent preclinical and clinical development until its approval by regulatory authorities. Particular emphasis has been given to specific aspects of the development process including lead generation and optimization, pharmacokinetics, ADME analysis, pharmacodynamics, toxicity and efficacy assessment, investigational new drug (IND) and new drug application (NDA) and the design of clinical trial and their phases. The book covers many aspects of modern personalized oncology and discusses economic aspects of our current system of developing new medicines and its impact on our societies and on future drug research. The author of this book, Dr. Link counts with more than 20 years of experience in biomedical research reflected in numerous publications, patents and key note and plenary presentations at international conferences. Interested readers, students and teachers should read this book as it provides a unique way to learn/teach about basic concepts in oncology and anti-cancer drug research.

ISBN: 9783030187224$q(electronic bk.)

Standard No.: 10.1007/978-3-030-18722-4doiSubjects--Topical Terms:

194707
Cancer
--Chemotherapy.

LC Class. No.: RC271.C5 / L565 2019

Dewey Class. No.: 616.994061

Principles of cancer treatment and anticancer drug development
LDR:02889nmm a2200325 a 4500 001 566238
003 DE-He213
005 20191217143238.0
006 m d
007 cr nn 008maaau
008 200429s2019 gw s 0 eng d
020 $a 9783030187224$q(electronic bk.)
020 $a 9783030187217$q(paper)
024 7 $a 10.1007/978-3-030-18722-4 $2 doi
035 $a 978-3-030-18722-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.C5 $b L565 2019
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994061 $2 23
090 $a RC271.C5 $b L756 2019
100 1 $a Link, Wolfgang. $3 851850
245 1 0 $a Principles of cancer treatment and anticancer drug development $h [electronic resource] / $c by Wolfgang Link.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2019.
300 $a xiv, 145 p. : $b ill. (some col.), digital ; $c 24 cm.
505 0 $a Preface -- Acknowledgements -- Contents -- Abbreviations -- Introduction -- Cancer Therapy -- Cancer drug resistance -- Drug Discovery and Development -- Economic and social implications of modern drug discovery. Index.
520 $a This book explains how current medicines against cancer work and how we find new ones. It provides an easy-to-understand overview of current options to treat patients with cancer, which includes Surgery, Radiation therapy, Chemotherapy, Targeted therapy and Immunotherapy. The efficiency of all these treatments is limited by the capacity of cancer cells to escape therapy. This book explains the mechanisms of anti-cancer drug resistance and strategies to overcome it. The discovery and development process of a new drug is detailed beginning with the identification and validation of a therapeutic target, the identification of an inhibitor of the target and its subsequent preclinical and clinical development until its approval by regulatory authorities. Particular emphasis has been given to specific aspects of the development process including lead generation and optimization, pharmacokinetics, ADME analysis, pharmacodynamics, toxicity and efficacy assessment, investigational new drug (IND) and new drug application (NDA) and the design of clinical trial and their phases. The book covers many aspects of modern personalized oncology and discusses economic aspects of our current system of developing new medicines and its impact on our societies and on future drug research. The author of this book, Dr. Link counts with more than 20 years of experience in biomedical research reflected in numerous publications, patents and key note and plenary presentations at international conferences. Interested readers, students and teachers should read this book as it provides a unique way to learn/teach about basic concepts in oncology and anti-cancer drug research.
650 0 $a Cancer $x Chemotherapy. $3 194707
650 0 $a Cancer $x Chemoprevention. $3 286215
650 0 $a Drug resistance in cancer cells. $3 281104
650 0 $a Cancer $x Treatment. $3 252269
650 1 4 $a Cancer Research. $3 273660
650 2 4 $a Molecular Medicine. $3 273932
650 2 4 $a Pharmaceutical Sciences/Technology. $3 338426
650 2 4 $a Biomedical Engineering/Biotechnology. $3 730838
650 2 4 $a Laboratory Medicine. $3 276727
650 2 4 $a Drug Resistance. $3 338425
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-3-030-18722-4
950 $a Biomedical and Life Sciences (Springer-11642)